🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

PRESS DIGEST- New York Times business news - March 1

Published 2016-03-01, 12:39 a/m
© Reuters.  PRESS DIGEST- New York Times business news - March 1
AAPL
-
BHC
-

March 1(Reuters) - The following are the top stories on the
New York Times business pages. Reuters has not verified these
stories and does not vouch for their accuracy.

- A federal magistrate judge on Monday denied the United
States government's request that Apple AAPL.O extract data
from an iPhone in a drug case in New York, giving the company's
pro-privacy stance a boost as it battles law enforcement
officials over opening up the device in other cases.

Valeant Pharmaceuticals (N:VRX) International VRX.TO said on
Monday it was being investigated by the Securities and Exchange
Commission, the latest turn of events for the Canadian drug
maker, which has come under recent scrutiny for its sky-high
drug prices and a once-secret relationship with a mail-order
pharmacy.

A non-profit watchdog group on Monday called for an
investigation of David Stevens, chief executive of Mortgage
Bankers Association, arguing that he may have violated ethics
laws relating to his previous position as commissioner of the
Federal Housing Administration.

Argentina has agreed to pay $4.65 billion to four hedge
funds in a deal that could put an end to more than a decade of
mudslinging and legal attacks that had cut the country off from
global financial markets.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.